156 related articles for article (PubMed ID: 19929131)
1. Autocrine effects of visfatin on hepatocyte sensitivity to insulin action.
Skop V; Kontrová K; Zídek V; Pravenec M; Kazdová L; Mikulík K; Sajdok J; Zídková J
Physiol Res; 2010; 59(4):615-618. PubMed ID: 19929131
[TBL] [Abstract][Full Text] [Related]
2. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.
Revollo JR; Körner A; Mills KF; Satoh A; Wang T; Garten A; Dasgupta B; Sasaki Y; Wolberger C; Townsend RR; Milbrandt J; Kiess W; Imai S
Cell Metab; 2007 Nov; 6(5):363-75. PubMed ID: 17983582
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
[TBL] [Abstract][Full Text] [Related]
4. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
6. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
Jacques C; Holzenberger M; Mladenovic Z; Salvat C; Pecchi E; Berenbaum F; Gosset M
J Biol Chem; 2012 Apr; 287(18):15100-8. PubMed ID: 22399297
[TBL] [Abstract][Full Text] [Related]
8. Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes.
Wanecq E; Prévot D; Carpéné C
J Physiol Biochem; 2009 Dec; 65(4):351-9. PubMed ID: 20358348
[TBL] [Abstract][Full Text] [Related]
9. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.
Imai S
Curr Pharm Des; 2009; 15(1):20-8. PubMed ID: 19149599
[TBL] [Abstract][Full Text] [Related]
11. Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes.
Choi YJ; Choi SE; Ha ES; Kang Y; Han SJ; Kim DJ; Lee KW; Kim HJ
Metabolism; 2011 Dec; 60(12):1781-9. PubMed ID: 21664630
[TBL] [Abstract][Full Text] [Related]
12. Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury.
Zhao Y; Liu XZ; Tian WW; Guan YF; Wang P; Miao CY
CNS Neurosci Ther; 2014 Jun; 20(6):539-47. PubMed ID: 24750959
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
14. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
[TBL] [Abstract][Full Text] [Related]
15. Liver X Receptor (LXR) activation negatively regulates visfatin expression in macrophages.
Mayi TH; Rigamonti E; Pattou F; Staels B; Chinetti-Gbaguidi G
Biochem Biophys Res Commun; 2011 Jan; 404(1):458-62. PubMed ID: 21145308
[TBL] [Abstract][Full Text] [Related]
16. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
Song HK; Lee MH; Kim BK; Park YG; Ko GJ; Kang YS; Han JY; Han SY; Han KH; Kim HK; Cha DR
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1485-94. PubMed ID: 18768589
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of nampt in human islets.
Kover K; Tong PY; Watkins D; Clements M; Stehno-Bittel L; Novikova L; Bittel D; Kibiryeva N; Stuhlsatz J; Yan Y; Ye SQ; Moore WV
PLoS One; 2013; 8(3):e58767. PubMed ID: 23536823
[TBL] [Abstract][Full Text] [Related]
19. Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders.
Dakroub A; A Nasser S; Younis N; Bhagani H; Al-Dhaheri Y; Pintus G; Eid AA; El-Yazbi AF; Eid AH
Cells; 2020 Nov; 9(11):. PubMed ID: 33182523
[TBL] [Abstract][Full Text] [Related]
20. The role of visfatin/ NAMPT in the regulation of feeding in goldfish (Carassius auratus).
Butler MJ; Volkoff H
Peptides; 2023 Feb; 160():170919. PubMed ID: 36503895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
